Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18060
Country/Region: Tanzania
Year: 2018
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $16,043,814 Additional Pipeline Funding: $2,500,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,314,709
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $730,395
Care: Pediatric Care and Support (PDCS) $146,078
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $2,191,179
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,435,954
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $9,056,871
Treatment: Pediatric Treatment (PDTX) $1,168,628
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 1,272
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 1,127
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 795
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 338
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 1,625
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 1,424
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 1,064
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 244
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 420
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 122
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 11
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 54
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 9,278
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 2,932
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 1
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 7,318
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 2,288
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 6
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 9,107
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 2,466
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 4
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 5,032
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 1,646
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 3
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 7,510
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 1,842
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 2
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 982
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 75
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 322
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 7
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 14,590
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 44,961
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 14,727
GEND_GBV Number of people receiving post-GBV care 2019 59,688
HTS_TST <5, Unknown Sex, Negative 2019 2,247
HTS_TST 15-19, Female, Negative 2019 517
HTS_TST 15-19, Male, Negative 2019 329
HTS_TST 20-24, Female, Negative 2019 866
HTS_TST 20-24, Male, Negative 2019 623
HTS_TST 25-29, Female, Negative 2019 6,435
HTS_TST 25-29, Female, Negative 2019 3,680
HTS_TST 25-29, Female, Negative 2019 3,814
HTS_TST 25-29, Female, Negative 2019 41,854
HTS_TST 25-29, Female, Negative 2019 54,683
HTS_TST 25-29, Female, Negative 2019 1,195
HTS_TST 25-29, Male, Negative 2019 974
HTS_TST 25-29, Male, Negative 2019 4,482
HTS_TST 25-29, Male, Negative 2019 3,025
HTS_TST 25-29, Male, Negative 2019 2,454
HTS_TST 25-29, Male, Negative 2019 30,012
HTS_TST 30-34, Female, Negative 2019 1,698
HTS_TST 30-34, Female, Negative 2019 8,681
HTS_TST 30-34, Female, Negative 2019 5,241
HTS_TST 30-34, Female, Negative 2019 4,360
HTS_TST 30-34, Female, Negative 2019 52,142
HTS_TST 30-34, Female, Negative 2019 54,683
HTS_TST 30-34, Male, Negative 2019 1,041
HTS_TST 30-34, Male, Negative 2019 4,730
HTS_TST 30-34, Male, Negative 2019 3,227
HTS_TST 30-34, Male, Negative 2019 2,519
HTS_TST 30-34, Male, Negative 2019 33,231
HTS_TST 35-39, Female, Negative 2019 1,801
HTS_TST 35-39, Female, Negative 2019 9,184
HTS_TST 35-39, Female, Negative 2019 5,485
HTS_TST 35-39, Female, Negative 2019 4,791
HTS_TST 35-39, Female, Negative 2019 58,007
HTS_TST 35-39, Female, Negative 2019 54,683
HTS_TST 35-39, Male, Negative 2019 1,186
HTS_TST 35-39, Male, Negative 2019 5,405
HTS_TST 35-39, Male, Negative 2019 3,663
HTS_TST 35-39, Male, Negative 2019 2,951
HTS_TST 35-39, Male, Negative 2019 37,710
HTS_TST 40-49, Female, Negative 2019 2,595
HTS_TST 40-49, Female, Negative 2019 12,479
HTS_TST 40-49, Female, Negative 2019 8,030
HTS_TST 40-49, Female, Negative 2019 7,248
HTS_TST 40-49, Female, Negative 2019 83,045
HTS_TST 40-49, Female, Negative 2019 82,025
HTS_TST 40-49, Male, Negative 2019 1,914
HTS_TST 40-49, Male, Negative 2019 9,115
HTS_TST 40-49, Male, Negative 2019 5,873
HTS_TST 40-49, Male, Negative 2019 4,710
HTS_TST 40-49, Male, Negative 2019 57,322
HTS_TST 50+, Female, Negative 2019 1,659
HTS_TST 50+, Male, Negative 2019 1,175
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 1,298,271
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 2
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 534
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 1,586
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 2,380
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 12,423
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 2,840
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 3,448
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 1,561
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,020
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 2,695
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1,939
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 4,954
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 3,511
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 2,601
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 11,198
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 2,459
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 3,319
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 1,174
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 813
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 2,438
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 1,390
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 5,341
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 3,605
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 88,729
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 20,664
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 26,455
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 14,334
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 10,368
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 26,931
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 18,636
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 59,483
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 40,824
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 34,029
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 1,298
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 6,867
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 1,383
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 1,876
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 2,309
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 1,603
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 4,527
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 2,803
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 9,253
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 6,377
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 16,002
HTS_TST_POS <5, Unknown Sex, Positive 2019 4
HTS_TST_POS 15-19, Female, Positive 2019 33
HTS_TST_POS 15-19, Male, Positive 2019 62
HTS_TST_POS 20-24, Female, Positive 2019 36
HTS_TST_POS 20-24, Male, Positive 2019 64
HTS_TST_POS 25-29, Female, Positive 2019 252
HTS_TST_POS 25-29, Female, Positive 2019 422
HTS_TST_POS 25-29, Female, Positive 2019 146
HTS_TST_POS 25-29, Female, Positive 2019 1,299
HTS_TST_POS 25-29, Female, Positive 2019 897
HTS_TST_POS 25-29, Female, Positive 2019 39
HTS_TST_POS 25-29, Male, Positive 2019 99
HTS_TST_POS 25-29, Male, Positive 2019 197
HTS_TST_POS 25-29, Male, Positive 2019 346
HTS_TST_POS 25-29, Male, Positive 2019 102
HTS_TST_POS 25-29, Male, Positive 2019 1,103
HTS_TST_POS 30-34, Female, Positive 2019 73
HTS_TST_POS 30-34, Female, Positive 2019 376
HTS_TST_POS 30-34, Female, Positive 2019 602
HTS_TST_POS 30-34, Female, Positive 2019 190
HTS_TST_POS 30-34, Female, Positive 2019 1,779
HTS_TST_POS 30-34, Female, Positive 2019 897
HTS_TST_POS 30-34, Male, Positive 2019 58
HTS_TST_POS 30-34, Male, Positive 2019 198
HTS_TST_POS 30-34, Male, Positive 2019 372
HTS_TST_POS 30-34, Male, Positive 2019 111
HTS_TST_POS 30-34, Male, Positive 2019 1,201
HTS_TST_POS 35-39, Female, Positive 2019 42
HTS_TST_POS 35-39, Female, Positive 2019 392
HTS_TST_POS 35-39, Female, Positive 2019 649
HTS_TST_POS 35-39, Female, Positive 2019 210
HTS_TST_POS 35-39, Female, Positive 2019 1,980
HTS_TST_POS 35-39, Female, Positive 2019 897
HTS_TST_POS 35-39, Male, Positive 2019 17
HTS_TST_POS 35-39, Male, Positive 2019 217
HTS_TST_POS 35-39, Male, Positive 2019 409
HTS_TST_POS 35-39, Male, Positive 2019 133
HTS_TST_POS 35-39, Male, Positive 2019 1,374
HTS_TST_POS 40-49, Female, Positive 2019 4
HTS_TST_POS 40-49, Female, Positive 2019 543
HTS_TST_POS 40-49, Female, Positive 2019 956
HTS_TST_POS 40-49, Female, Positive 2019 332
HTS_TST_POS 40-49, Female, Positive 2019 2,983
HTS_TST_POS 40-49, Female, Positive 2019 1,370
HTS_TST_POS 40-49, Male, Positive 2019 26
HTS_TST_POS 40-49, Male, Positive 2019 400
HTS_TST_POS 40-49, Male, Positive 2019 684
HTS_TST_POS 40-49, Male, Positive 2019 215
HTS_TST_POS 40-49, Male, Positive 2019 2,108
HTS_TST_POS 50+, Female, Positive 2019 18
HTS_TST_POS 50+, Male, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 69
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 442
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 80
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 114
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 168
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 107
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 309
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 214
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 595
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 412
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 179
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 36
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 50
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 99
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 59
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 215
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 148
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 189
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 1,144
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 250
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 335
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 539
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 358
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 908
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 694
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 1,875
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 1,309
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 80
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 235
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 35
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 54
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 97
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 185
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 124
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 353
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 240
PMTCT_ART Already on ART at beginning of current pregnancy 2019 2,564
PMTCT_ART New on ART 2019 4,713
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 7,277
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 255,843
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 5,813
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,458
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 7,271
PMTCT_EID Sum of Infant Age disaggregates 2019 7,271
PMTCT_STAT 25-29, Female 2019 63,980
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 861
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 62,045
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 1,033
PMTCT_STAT 30-34, Female 2019 51,173
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 689
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 49,638
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 825
PMTCT_STAT 35-39, Female 2019 38,380
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 517
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 37,235
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 613
PMTCT_STAT 40-49, Female 2019 7,671
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 44
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 7,443
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 57
PMTCT_STAT By Age (Numerator): 10-14 2019 2,568
PMTCT_STAT By Age (Numerator): 15-19 2019 12,793
PMTCT_STAT By Age (Numerator): 20-24 2019 76,763
PMTCT_STAT By Age (Numerator): 50+ 2019 2,568
PMTCT_STAT By Number of known positives: 10-14 2019 3
PMTCT_STAT By Number of known positives: 15-19 2019 123
PMTCT_STAT By Number of known positives: 20-24 2019 1,045
PMTCT_STAT By Number of known positives: 50+ 2019 3
PMTCT_STAT By Number of new negative: 10-14 2019 2,486
PMTCT_STAT By Number of new negative: 15-19 2019 12,407
PMTCT_STAT By Number of new negative: 20-24 2019 74,454
PMTCT_STAT By Number of new negative: 50+ 2019 2,486
PMTCT_STAT By Number of new positives: 10-14 2019 5
PMTCT_STAT By Number of new positives: 15-19 2019 159
PMTCT_STAT By Number of new positives: 20-24 2019 1,240
PMTCT_STAT By Number of new positives: 50+ 2019 5
PMTCT_STAT Number of new ANC and L&D clients 2019 269,291
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 255,843
PMTCT_STAT_den 25-29, Female 2019 67,316
PMTCT_STAT_den 30-34, Female 2019 53,869
PMTCT_STAT_den 35-39, Female 2019 40,385
PMTCT_STAT_den 40-49, Female 2019 8,082
PMTCT_STAT_den By Age (Denominator): <15-19 2019 13,454
PMTCT_STAT_den By Age (Denominator): 10-14 2019 2,691
PMTCT_STAT_den By Age (Denominator): 20-24 2019 80,803
PMTCT_STAT_den By Age (Denominator): 50+ 2019 2,691
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 1,636
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 19,602
TB_PREV By Age/Sex (Numerator): <15, Female 2019 1,636
TB_PREV By Age/Sex (Numerator): <15, Male 2019 1,214
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 19,602
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 10,201
TB_PREV IPT, Life-long ART, Already, Positive 2019 1,214
TB_PREV IPT, Life-long ART, New, Positive 2019 10,201
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 32,653
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 38,405
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 1,174
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 840
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 24,872
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 11,513
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 1,739
TB_PREV_den IPT, Life-long ART, New, Positive 2019 36,666
TX_CURR 25-29, Female, Positive 2019 13,758
TX_CURR 25-29, Male, Positive 2019 3,804
TX_CURR 30-34, Female, Positive 2019 17,290
TX_CURR 30-34, Male, Positive 2019 5,701
TX_CURR 35-39, Female, Positive 2019 17,022
TX_CURR 35-39, Male, Positive 2019 7,349
TX_CURR 40-49, Female, Positive 2019 23,242
TX_CURR 40-49, Male, Positive 2019 13,015
TX_CURR Age/Sex: <1 2019 586
TX_CURR Age/Sex: <1-9 2019 7,183
TX_CURR Age/Sex: 10-14 Female 2019 2,726
TX_CURR Age/Sex: 10-14 Male 2019 2,765
TX_CURR Age/Sex: 15-19 Female 2019 2,859
TX_CURR Age/Sex: 15-19 Male 2019 1,943
TX_CURR Age/Sex: 20-24 Female 2019 5,173
TX_CURR Age/Sex: 20-24 Male 2019 1,907
TX_CURR Age/Sex: 50+ Female 2019 24,770
TX_CURR Age/Sex: 50+ Male 2019 15,774
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 166,921
TX_CURR Sum of age/sex disaggregates 2019 4,802
TX_NEW 25-29, Female, Positive 2019 2,659
TX_NEW 25-29, Male, Positive 2019 2,400
TX_NEW 30-34, Female, Positive 2019 3,810
TX_NEW 30-34, Male, Positive 2019 2,344
TX_NEW 35-39, Female, Positive 2019 4,008
TX_NEW 35-39, Male, Positive 2019 2,652
TX_NEW 40-49, Female, Positive 2019 5,793
TX_NEW 40-49, Male, Positive 2019 4,235
TX_NEW Breastfeeding status 2019 1,529
TX_NEW By Age/Sex: <1 2019 410
TX_NEW By Age/Sex: 1-9 2019 2,337
TX_NEW By Age/Sex: 10-14 Female 2019 494
TX_NEW By Age/Sex: 10-14 Male 2019 699
TX_NEW By Age/Sex: 15-19 Female 2019 1,096
TX_NEW By Age/Sex: 15-19 Male 2019 749
TX_NEW By Age/Sex: 20-24 Female 2019 1,942
TX_NEW By Age/Sex: 20-24 Male 2019 1,553
TX_NEW By Age/Sex: 50+ Female 2019 3,673
TX_NEW By Age/Sex: 50+ Male 2019 2,614
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 43,750
TX_NEW Pregnancy status 2019 4,036
TX_NEW Sum of Age/Sex disaggregates 2019 12,820
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 161,133
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 2,783
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 541
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 4,786
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 1,022
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 101,899
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 368
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 49,586
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 147
TX_PVLS_den Denominator: Indication: Routine 2019 158,193
TX_PVLS_den Denominator: Indication: Targeted 2019 2,959
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,283
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 628
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 27,566
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 13,030
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 42,516
TX_RET Numerator by Status: Breastfeeding 2019 1,886
TX_RET Numerator by Status: Pregnant 2019 5,820
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 47,242
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,425
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 714
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 30,623
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 14,482
TX_RET_den Denominator by Status: Breastfeeding 2019 2,101
TX_RET_den Denominator by Status: Pregnant 2019 6,456
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 138,142
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 4,939
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 4,763
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 88,939
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 39,510
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 6
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2019 2
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 503
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 512
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 107,577
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 3,002
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 26,806
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 699
Cross Cutting Budget Categories and Known Amounts Total: $2,748,329
Gender: Gender Based Violence (GBV) $523,906
Post GBV Care
Implementation
Capacity building
Water $50,000
Economic Strengthening $275,517
Human Resources for Health $1,898,906